Reviva Pharmaceuticals Inc Appoints Three New Board Members

SANTA CLARA, Calif.--(BUSINESS WIRE)--Reviva Pharmaceuticals, Inc., (Reviva), a privately held drug discovery and development company, announced today that it has appointed life sciences industry experts, Brian G. Atwood, Sarvajna Dwivedi and Peder K. Jensen to its Board of Directors. "We are extremely pleased to welcome Mr. Atwood, Dr. Jensen and Dr. Dwivedi to the Board," said Laxminarayan Bhat, Founder, President and Chief Executive Officer of Reviva.

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.